Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Genentech, Inc. patentsThe following is a sampling of recent Genentech, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Genentech, Inc. patents
20080095771 - Treatment method
20080095773 - Polypeptides homologous to vegf and bmp1
20080096215 - Compositions and methods for the diagnosis and treatment of tumor
20080085886 - Aza-benzofuranyl compounds and methods of use
20080081821 - Aza-benzothiophenyl compounds and methods of use
March 2008 - Genentech, Inc. patents
20080075719 - Method for augmenting b cell depletion
20080063641 - Monovalent antibody fragments useful as therapeutics
20080057066 - Methods and compositions for targeting relt
20080057503 - Methods and compositions for detecting autoimmune disorders
February 2008 - Genentech, Inc. patents
20080050310 - Antibodies and immunoconjugates and uses therefor
20080050364 - Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
20080050373 - Treatment with anti-erbb2 antibodies
20080050377 - Compositions and methods relating to stop-1
20080050758 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20080044415 - Hepatocyte growth factor receptor antagonists and uses thereof
20080044421 - Methods of using death receptor ligands and cd20 antibodies
20080038264 - Compositions and methods for the treatment of immune related diseases
20080038717 - Enrichment method for variant proteins with altered binding properties
20080031875 - Treatment method
20080031880 - Use of erbb receptor ligands in treating diabetes
20080032343 - Recombinant production of heparin binding proteins
January 2008 - Genentech, Inc. patents
20080025971 - Humanized anti-beta7 antagonists and uses therefor
20080026426 - Anti-infective therapy
20080014196 - Compositions and methods for modulating vascular development
20080008705 - Cancer prognostic diagnostic and treatment methods
20080003218 - Anti-ige antibodies
December 2007 - Genentech, Inc. patents
20070298036 - Pro71238 polypeptides
20070299052 - Inhibitors of iap
20070292419 - Treatment with anti-erbb2 antibodies
20070292438 - Novel gene disruptions, compositions and methods relating thereto
20070292936 - Binding polypeptides with optimized scaffolds
20070280931 - Antibody variants
November 2007 - Genentech, Inc. patents
20070274995 - Cardiotrophin-1 compositions and methods for the treatment of tumor
20070269371 - Antibodies with altered effector functions
20070269429 - Treatment with anti-erbb2 antibodies
20070269446 - Compositions and methods for the treatment of tumor of hematopoietic origin
20070264193 - Diagnostics and treatments for tumors
20070264259 - Methods for treating kidney disorders
20070264267 - Compositions and methods for treatment of cancer
20070264686 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20070258984 - Treatment with anti-vegf antibodies
20070259398 - Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry
20070253948 - Anti-fc-gamma riib receptor antibody and uses therefor
20070253959 - Vascular endothelial cell growth factor antagonists
20070254302 - Compositions and methods for the diagnosis and treatment of tumor
October 2007 - Genentech, Inc. patents
20070248588 - Novel compositions and methods for the treatment of immune-related diseases
20070248604 - Anti-fgf19 antibodies and methods using same
20070248610 - Anti-vegf antibodies
20070250941 - Vegf receptor conditional knockout animals and methods of use
20070243193 - Compositions and methods for the diagnosis and treatment of tumor
20070237774 - Method for using boc/cdo to modulate hedgehog signaling
20070238642 - Production of vascular endothelial cell growth factor and dna encoding same
20070238859 - Pro9925 polypeptides
20070231323 - Compositions and methods for the diagnosis and treatment of tumors of glial origin
20070231324 - Methods of using death receptor ligands and cd20 antibodies
20070231328 - Method of treatment using humanized anti-cd11a antibodies
September 2007 - Genentech, Inc. patents
20070224185 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20070224201 - Compositions and methods for the diagnosis and treatment of tumor
20070218069 - Methods and compositions for targeting polyubiquitin
20070212356 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
20070212362 - Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis
20070212735 - Compositions and methods for the diagnosis and treatment of tumor
20070207142 - Compositions and methods for the treatment of tumor of hematopoietic origin
20070207147 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
August 2007 - Genentech, Inc. patents
20070202045 - Serum albumin binding peptides for tumor targeting
20070202516 - Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
20070196374 - Anti-vegf antibodies
20070190058 - Method for treating intraocular neovascular diseases
20070184055 - Treatment with anti-erbb2 antibodies
20070184444 - Compositions and methods for the treatment of immune related diseases
20070185017 - Compositions and methods for the treatment of immune related diseases
20070178486 - Compositions and methods for the diagnosis and treatment of tumor
20070178539 - Novel cytokine receptors and nucleic acids encoding the same
20070179088 - Foggy
20070179091 - Hedgehog kinases and their use in modulating hedgehog signaling
July 2007 - Genentech, Inc. patents
20070174922 - Nucleic acid encoding novel type-1 cytokine receptor glm-r
20070166753 - Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
20070160576 - Il-17a/f heterologous polypeptides and therapeutic uses thereof
20070160594 - Method of diagnosing and treating cartilaginous disorders
20070160598 - Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
20070160608 - Treatment with anti-vegf antibodies
20070160612 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
20070160618 - Cardiotrophin-1 compositions and methods for the treatment of tumor
20070161061 - Novel composition and methods for the treatment of immune related diseases
20070161558 - Production of vascular endothelial cell growth factor and dna encoding same
20070161564 - Methods for making apo-2 ligand using divalent metal ions
20070154391 - Antibodies to vascular endothelial cell growth factor
20070154483 - Treatment with anti-vegf antibodies
June 2007 - Genentech, Inc. patents
20070148177 - Treatment with anti-vegf antibodies
20070148178 - Treatment with anti-vegf antibodies
20070141023 - Assays and methods using biomarkers
20070141066 - Method for diagnosing, prognosing and treating glioma
20070141068 - Methods for the treatment of carcinoma
20070141630 - Identification of non-covalent complexes by mass spectrometry
20070143871 - Non-human transgenic animal models for hepatocellular carcinoma
20070134243 - Antibody drug conjugates and methods
20070134251 - Assays and methods using biomarkers
20070136829 - Novel type-1 cytokine receptor glm-r
20070129301 - Methods and compositions for modulating hgf/met
May 2007 - Genentech, Inc. patents
20070122394 - Compositions and methods for liver growth and liver protection
20070122407 - Isolated nucleic acids, vectors and host cells encoding erbb3 antibodies
20070116700 - Reduced-viscosity concentrated protein formulations
20070117124 - Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
20070110755 - Vascular endothelial cell growth factor antagonists
20070098634 - Compositions and methods for the diagnosis and treatment of tumor
20070098681 - Apo-2 ligand/trail variants and uses thereof
20070098707 - Methods and compositions for inhibiting c-met dimerization and activation
April 2007 - Genentech, Inc. patents
20070092520 - Humanized anti-cmet antagonists
20070092890 - Methods and compositions for detecting autoimmune disorders
20070092940 - Cysteine engineered antibodies and conjugates
20070086995 - Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations
20070087006 - Compositions and methods for the diagnosis and treatment of tumor
20070081995 - Methods and compositions for targeting ifnar2
20070077243 - Method for making humanized antibodies
20070077625 - Purification of polypeptides
20070077626 - Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same
March 2007 - Genentech, Inc. patents
20070048218 - Compositions and methods for the diagnosis and treatment of tumor
20070048301 - Compositions and methods for the treatment of immune related diseases
20070048326 - Compositions and methods for the diagnosis and treatment of tumor
20070048822 - Erbb4 receptor-specific neuregulin related ligands and uses therefor
20070048825 - Compositions and methods for the diagnosis and treatment of tumor
20070049516 - Use of insulin for the treatment of cartilaginous disorders
20070049601 - Benzofuran inhibitors of factor viia
20070049730 - Patched-2 antibodies
February 2007 - Genentech, Inc. patents
20070041969 - Apo-2dcr
20070041970 - Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
20070041983 - Method for treating tumors using anti-osteopontin antibodies
20070042415 - Anti-fused antibodies
20070042395 - Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
20070042466 - Il-1 related polypeptides
20070042945 - Nouvelles compositions et methods de traitement du psoriasis
20070036753 - Treatment with anti-vegf antibodies
20070036754 - Treatment with anti-vegf antibodies
20070036755 - Treatment with anti-vegf antibodies
20070036782 - Apo-2 ligand
20070036790 - Treatment with anti-vegf antibodies
20070036813 - Vegf-related protein
20070037148 - Compositions and methods for the treatmetn of natural killer cell related diseases
20070037191 - Apo-2dcr
20070037254 - Expression vectors and methods
20070037255 - Antibody variants with faster antigen association rates
20070037741 - Novel compositions and methods for the treatment of immune related disease
20070037813 - Serine protease inhibitors
20070037814 - Acylsulfamide inhibitors of factor viia
20070031331 - Treatment of disorders
20070031413 - Treatment with anti-vegf antibodies
20070031437 - Compositions and methods for modulating vascular development
20070031901 - Compositions and methods for the diagnosis and treatment of tumor
20070031929 - Polypeptides homologous to vegf and bmp1
20070025987 - Method for treating vasculitis
20070025988 - Method for treating lupus
20070025999 - Treatment with anti-vegf antibodies
20070026000 - Apo-2l receptor agonist and cpt-11 synergism
20070026001 - Apo-2 ligand-anti-her-2 antibody synergism
20070026002 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use
20070026044 - Use of vegf for treating bone defects
20070026450 - Methods for the treatment of carcinoma
20070026496 - Process for producing polypeptides
20070027083 - Human growth hormone aqueous formulation
January 2007 - Genentech, Inc. patents
20070020256 - Methods for treatment of allergic asthma
20070020258 - Immunoglobulin variants
20070020260 - Glycoprotein compositions
20070020264 - Serum albumin binding peptides for tumor targeting
20070020276 - Methods for the treatment of carcinoma
20070021342 - Wound healing
20070014779 - Plasminogen activator variant formulations
20070014794 - Method for making heteromultimeric polypeptides
20070014797 - Method for treating sjogren's syndrome
20070015228 - Assay for antibodies
20070015247 - Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
20070009523 - Polypeptide variants with altered effector function
20070010434 - Novel compositions and methods for the treatment of immune related diseases
20070004009 - Methods for making recombinant proteins using apoptosis inhibitors
December 2006 - Genentech, Inc. patents
20060292150 - Methods of using wisp antagonists
20060293235 - Hgf beta chain variants
20060286640 - Process for production of polypeptides
20060287234 - Wound healing
20060281146 - Novel compositions and methods for the treatment of immune related diseases
20060281680 - Methods and compositions for modulating vascular integrity
20060275306 - Protein formulation
20060276435 - Fibroblast activation protein inhibitor compounds and methods
November 2006 - Genentech, Inc. patents
20060270003 - Il-17a/f heterologous polypeptides and therapeutic uses thereof
20060270594 - Methods and compositions for modulating hyperstabilized c-met
20060263349 - Pretreatment of a biological sample from an autoimmune disease subject
20060263774 - Compositions and methods for the treatment of immune related diseases
20060263808 - C-met mutations in lung cancer
20060257390 - Catheter composition and uses thereof
20060257971 - Antibodies to pro1561 polypeptide
20060258574 - Novel compositions and methods for the treatment of psoriasis
20060251662 - Compositions and methods for the treatment of tumor of hematopoietic origin
20060246004 - Antibody variants and uses thereof
20060246050 - Catheter composition and uses thereof
20060246471 - Compositions and methods for screening pro-apoptotic compounds
October 2006 - Genentech, Inc. patents
20060240007 - Method for treating dementia or alzheimer's disease
20060240008 - Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
20060233797 - Treatment of inflammatory bowel disease (ibd)
20060234306 - Assay method
20060228364 - Serum albumin binding peptides for tumor targeting
20060228745 - Gene detection assay for improving the likelhood of an effective response to an erbb antagonist cancer therapy
September 2006 - Genentech, Inc. patents
20060210556 - Novel composition and methods for the treatment of immune disorders
20060210561 - Dosages for treatment with anti-egfr antibodies
20060210570 - Methods and compositions for modulating prostasin
20060211612 - Angiogenesis using hepatocyte growth factor
20060204493 - Heteromultimeric molecules
20060198843 - Treatment with anti-erbb2 antibodies and chemotherapeutic agents
20060199181 - Compositions and methods for the treatment of immune related diseases
August 2006 - Genentech, Inc. patents
20060193851 - Human anti-factor ix/ixa antibodies
20060193854 - Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
20060193862 - Vascular endothelial cell growth factor antagonists
20060194283 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
20060194290 - Polypeptide variants with altered effector function
20060194291 - Polypeptide variants with altered effector function
20060194954 - Polypeptide variants
20060194957 - Polypeptide variants with altered effector function
20060188495 - Treatment method
20060188498 - Methods of using death receptor agonists and egfr inhibitors
20060188509 - Extending time to disease progression or survival in cancer patients
20060182739 - Protein purification
20060182751 - Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
20060182755 - Novel composition and methods for the treatment of psoriasis
20060183784 - Human growth hormone antagonists
20060177448 - Inhibiting her2 shedding with matrix metalloprotease antagonists
20060177897 - Pr1550 polypeptides and nucleic acids encoding the same
July 2006 - Genentech, Inc. patents
20060165702 - Fixed dosing of her antibodies
20060167066 - Pyrrolidine inhibitors of iap
20060160997 - Compositions and methods for the diagnosis and treatment of tumor
20060147373 - Compositions and methods for the diagnosis and treatment of tumor
20060147374 - Compositions and methods for the diagnosis and treatment of tumor
20060147451 - Modulators of hepatocyte growth factor activator
20060147453 - Methods and compositions for modulating and detecting wisp activity
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Genentech, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Genentech, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
